About
Technology
Issues
FAQ
Links
Official Page
An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
